Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pregnancy heart study aims to predict hidden risks

NCT ID NCT07376616

Knowledge-focused Sponsor: Fundacin Biomedica Galicia Sur Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 242 pregnant women to measure how their heart rate and blood pressure change from the third month of pregnancy through the postpartum period. Researchers use non-invasive tests like ECG and blood pressure cuffs to understand the body's natural adjustments. The goal is to learn more about normal heart function during pregnancy and find ways to predict potential complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better monitor heart health during pregnancy and spot early warning signs of complications.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve health outcomes, and results may not apply to all pregnant women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 242 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women pregnant from the first trimester of gestation over 18 years.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Over 18 years of age * Pregnancy from the third month of gestation * No pre-existing cardiovascular disease * Good cognitive level * Sign informed consent Exclusion Criteria: * Diabetes mellitus * Hyperthyroidism * Hypothyroidism * Chronic hypertension diagnosed before pregnancy * Heart failure * Ischemic heart disease or malignant ventricular arrhythmias (ventricular fibrillation, ventricular tachycardia, grade 2 or 3 AV block, atrial fibrillation in patients with Wolff-Parkinson- White syndrome, paroxysmal fibrillation or flutter with rapid ventricular response and hemodynamic deterioration, uncontrolled supraventricular tachycardia) * Exercise-induced ischaemia * Unstable angina * Disease not susceptible to revascularization * Associated valvular heart disease * Chronic kidney disease * Degenerative neurological condition * Brain aneurysms * Arteriovenous malformations * History of transient cerebral infarction (ICTUS) * Migraines diagnosed * Epilepsy * Brain or spinal cord injury * Tumors * Diseases of the respiratory tract * Diseases of lung tissue * Diseases of pulmonary circulation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart rate variation (HRV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart rate variation (HRV) Hemodynamics Pregnancy related

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Alvaro Cunqueiro

    RECRUITING

    Vigo, Pontevedra, 36312, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.